Related Experiment Videos

[Pathomorphology and classification of prostatic cancer]

R Yatani, I Kusano, T Shiraishi

Rinsho Byori. the Japanese Journal of Clinical Pathology

|July 1, 1986

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Machine-learning-based high-temporal-resolution electron temperature evaluation from photomultiplier tube signals in GAMMA 10/PDX: A tandem mirror plasma confinement device.

The Review of scientific instruments·2026

Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer.

ESMO open·2022

Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours.

ESMO open·2021

Erlotinib plus bevacizumab vs erlotinib monotherapy as first-line treatment for advanced EGFR mutation-positive non-squamous non-small-cell lung cancer: Survival follow-up results of the randomized JO25567 study.

Lung cancer (Amsterdam, Netherlands)·2020

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

See all related articles